[The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension]
- PMID: 1250586
[The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension]
Similar articles
-
[Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].Ugeskr Laeger. 1973 May 17;135(20):968-70. Ugeskr Laeger. 1973. PMID: 4755952 Clinical Trial. Danish. No abstract available.
-
[The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].Rev Med Suisse Romande. 1988 Jun;108(6):529-33. Rev Med Suisse Romande. 1988. PMID: 2901140 French. No abstract available.
-
Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension.Mayo Clin Proc. 1983 May;58(5):315-8. Mayo Clin Proc. 1983. PMID: 6843182 Clinical Trial.
-
[Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].Klin Med (Mosk). 1983 Sep;61(9):85-9. Klin Med (Mosk). 1983. PMID: 6139506 Review. Russian. No abstract available.
-
Antihypertensive effects of pindolol.Am Heart J. 1982 Aug;104(2 Pt 2):374-87. doi: 10.1016/0002-8703(82)90128-4. Am Heart J. 1982. PMID: 7048877 Review. No abstract available.